New Key Statistics Module, Z-Score and F-Score
NAS:PYXS Key Ratios
| Market Cap $ M | 92.17 |
| Enterprise Value $ M | -32.11 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.60 |
| Price/Sales | 4.92 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 16.00 |
| EPS (TTM) $ | -1.03 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 0.48 |
| EV-to-EBITDA | 0.50 |
| PEG | -- |
| Shares Outstanding M | 59.47 |
| Net Margin (%) | -355.24 |
| Operating Margin % | -415.94 |
| Pre-tax Margin (%) | -355.24 |
| Quick Ratio | 7.33 |
| Current Ratio | 7.33 |
| ROA % (ttm) | -29.13 |
| ROE % (ttm) | -37.18 |
| ROIC % (ttm) | -126.15 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.12 |
PYXS Number of Guru Trades
PYXS Volume of Guru Trades
Gurus Latest Trades with NAS:PYXS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PYXS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pyxis Oncology Inc Insider Transactions
No Available Data
News about NAS:PYXS
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers